Betulin
CAS 473-98-3
Betulin (CAS 473-98-3) is a pharmaceutical compound with 6 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 32229.709777777778 nM | 87 | - |
| - | GI50 | 27041.46807692308 nM | 52 | - |
| - | EC50 | 27728.55818181818 nM | 32 | - |
| - | GI50 | 9.450000000000001 ug.mL-1 | 12 | - |
| - | IC50 | 8.2 ug.mL-1 | 5 | - |
| - | Ki | 2500 nM | 2 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| BETULIN | 2467840 | SU | MTHSPL |
| betulin | 2467840 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Betulin used for in pharmaceutical contexts?
Betulin (CAS 473-98-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Betulin?
No adverse-event association or SIDER side-effect rows are rendered for Betulin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Betulin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Betulin with EU status "permitted".
What clinical phase is Betulin in?
No phase 1-4 clinical development badge is rendered for Betulin because the matched compound identifier rows do not contain a max-phase value.